REG - BioPharma Credit PLC - Investor Presentation via Investor Meet Company

Biopharma CreditAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260410:nRSJ9002Za&default-theme=true

RNS Number : 9002Z  BioPharma Credit PLC  10 April 2026

10 April 2026

BioPharma Credit PLC

(the "Company")

 

Investor Presentation via Investor Meet Company

 

BioPharma Credit PLC announces that the Company's Investment Adviser,
Pharmakon Advisors, LP, will provide a live presentation via Investor Meet
Company on 21 April 2026 at 15:00 BST.

 

The presentation is open to existing and potential shareholders and will
provide an overview of the Company's investment strategy and portfolio.

 

Questions can be submitted pre-event via your Investor Meet Company dashboard
up until 20 April 2026 at 09:00am BST, or at any time during the live
presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet the
Company via:
(https://www.investormeetcompany.com/ashoka-whiteoak-emerging-markets-trust-plc/register-investor)
 

https://www.investormeetcompany.com/biopharma-credit-plc/register-investor
(https://www.investormeetcompany.com/biopharma-credit-plc/register-investor)

 

Investors who already follow the Company on the Investor Meet Company
platform will automatically be invited.

 

- ENDS -

 

For further information:

 

Enquiries:

 

BioPharma Credit plc

via MUFG Corporate Governance Limited

Company Secretary

+44 (0) 333 300 1932

 

Burson Buchanan

Henry Wilson / Helen Tarbet / Jamie Hooper / Nick Croysdill

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

 

Notes to Editors:

 

BioPharma Credit PLC is London's only specialist debt investor to the life
sciences industry and joined the LSE in March 2017. BioPharma Credit
PLC seeks to provide long-term shareholder returns, principally in the form
of sustainable income distributions from exposure to the life sciences
industry. BioPharma Credit PLC seeks to achieve this objective primarily
through investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCGZGGDLLRGVZM



            Copyright 2019 Regulatory News Service, all rights reserved